Lite Strategy, Inc. (LITS)
| Market Cap | 39.63M +191.4% |
| Revenue (ttm) | n/a |
| Net Income | -60.82M |
| EPS | -2.21 |
| Shares Out | 36.36M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 222,259 |
| Open | 1.080 |
| Previous Close | 1.095 |
| Day's Range | 1.080 - 1.110 |
| 52-Week Range | 0.951 - 9.000 |
| Beta | 0.08 |
| Analysts | Hold |
| Price Target | 20.00 (+1,734.86%) |
| Earnings Date | May 13, 2026 |
About LITS
Lite Strategy, Inc. a clinical-stage pharmaceutical company, focuses on the development of novel and differentiated therapies for the treatment of cancer. The company was formerly known as MEI Pharma, Inc. and changed its name to Lite Strategy, Inc. in September 2025. Lite Strategy, Inc. was incorporated in 2000 and is based in San Diego, California.
Financial Performance
Financial StatementsAnalyst Summary
According to one analyst, the rating for LITS stock is "Hold" and the 12-month stock price target is $20.0.
News
Lite Strategy Reports Fiscal 2026 Third Quarter Results
SAN DIEGO, May 13, 2026 (GLOBE NEWSWIRE) -- Lite Strategy, Inc. (Nasdaq: LITS) (“Lite Strategy” or the “Company”), the first U.S. public company to adopt Litecoin (LTC) as its primary treasury reserve...
Lite Strategy Quarterly report: Q3 2026
Lite Strategy has published its Q3 2026 quarterly earnings report on May 13, 2026.
Lite Strategy Earnings release: Q3 2026
Lite Strategy released its Q3 2026 earnings on May 13, 2026, summarizing the period's financial results.
Lite Strategy reports Q2 EPS (82c) vs. (40c) last year
“The second quarter marked a pivotal shift in our evolution. We moved from simply accumulating LTC to launching our first active capital market operations to create value for stockholders and…
Lite Strategy to continue to evaluate strategic investments in 2H of 2026
Over the second half of fiscal 2026, Lite Strategy (LITS)plans to continue to implement selective strategies in tandem with the experienced treasury management team at GSR, a leading crypto investment...
Lite Strategy Reports Fiscal 2026 Second Quarter Results
SAN DIEGO, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Lite Strategy, Inc. (Nasdaq: LITS) (“Lite Strategy” or the “Company”), the first U.S. public company to adopt Litecoin (LTC) as its primary treasury reserv...
Lite Strategy Earnings release: Q2 2026
Lite Strategy released its Q2 2026 earnings on February 17, 2026, summarizing the period's financial results.
Lite Strategy Quarterly report: Q2 2026
Lite Strategy has published its Q2 2026 quarterly earnings report on February 17, 2026.
Lite Strategy Proxy statement: Proxy Filing
Lite Strategy filed a proxy statement on January 27, 2026, providing details for shareholder voting and corporate governance matters.
Lite Strategy Proxy statement: Proxy Filing
Lite Strategy filed a proxy statement on December 30, 2025, providing details for shareholder voting and corporate governance matters.
Lite Strategy Proxy statement: Proxy Filing
Lite Strategy filed a proxy statement on December 30, 2025, providing details for shareholder voting and corporate governance matters.
Lite Strategy names acting CEO Justin File to role on a permanent basis
In a regulatory filing, Lite Strategy (LITS)disclosed that on November 14, the Board, upon the recommendation of the Nominating and Governance Committee of the Board, approved the election of acting…
Lite Strategy reports Q1 results, highlights launch of $100M Litecoin Treasury
“Our first quarter was incredibly successful for LITS. We launched our digital treasury strategy, positioning ourselves as the leading public holder of LTC, and updated our corporate profile to reinfo...
Lite Strategy Quarterly report: Q1 2026
Lite Strategy has published its Q1 2026 quarterly earnings report on November 14, 2025.
Lite Strategy announces $25M share repurchase program
Lite Strategy (LITS)announced its Board of Directors has authorized a program to repurchase shares of the Company’s Common Stock, par value $0.00000002 per share, up to an aggregate amount of…
Lite Strategy files to sell 780,497 shares of common stock for holders
16:48 EDT Lite Strategy (LITS)files to sell 780,497 shares of common stock for holders
Lite Strategy Registration statement: Registration Filing
Lite Strategy filed a registration statement on October 8, 2025, providing details about a securities offering with the SEC.
Lite Strategy Annual report: Q4 2025
Lite Strategy has published its Q4 2025 annual report on September 26, 2025.
MEI Pharma, Inc. Rebrands as Lite Strategy, Inc., Adopts New NASDAQ Ticker ‘LITS'
SAN DIEGO--(BUSINESS WIRE)--MEI Pharma, Inc. (NASDAQ: MEIP) (“MEI” or the “Company”) today announced that it will change its corporate name to Lite Strategy, Inc., reflecting the Company's expansion i...
Lite Strategy Registration statement: Registration Filing
Lite Strategy filed a registration statement on August 26, 2025, providing details about a securities offering with the SEC.
Lite Strategy Registration statement: Registration Filing
Lite Strategy filed a registration statement on August 6, 2025, providing details about a securities offering with the SEC.
MEI Pharma Acquires Litecoin, Launches $100M Institutional Treasury Strategy with Charlie Lee and GSR Advising
SAN DIEGO--(BUSINESS WIRE)--MEI Pharma, Inc. (NASDAQ: MEIP) (“MEI” or “the Company”) today announced the acquisition of 929,548 Litecoin (LTC) tokens at an average price of $107.58, successfully launc...
BTC digital asset field continues to exert its strength, HASHJ launches Bitcoin cloud mining platform with "capital + technology" dual-driven mode
[UK, July 24, 2025] - BTC As the blockchain industry enters a new round of market cycle, the multi-currency linkage effect gradually emerges, and the price of BTC today starts to rise at 118875.30. Ac...
MEI Pharma Announces Closing of $100,000,000 Private Placement to Initiate Litecoin Treasury Strategy, Becoming First and Only Publicly Traded LTC Holder on a National Exchange
SAN DIEGO--(BUSINESS WIRE)--MEI Pharma Announces Closing of $100,000,000 Private Placement to Initiate Litecoin Treasury Strategy.
MEI Pharma Announces $100,000,000 Private Placement to Initiate Litecoin Treasury Strategy, Becoming First and Only Publicly Traded LTC Holder on a National Exchange
SAN DIEGO--(BUSINESS WIRE)--MEI Pharma, Inc. (Nasdaq: MEIP) (the “Company” or “MEI”) today announced that it has entered into securities purchase agreements for a private investment in public equity (...